Los Angeles Capital Management’s Intellia Therapeutics NTLA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q4 | $17.8K | Buy |
|
|||||
|
2024
Q3 | – | Sell |
|
|||||
|
2024
Q2 | $234K | Sell |
|
|||||
|
2024
Q1 | $480K | Buy |
|
|||||
|
2023
Q4 | $357K | Buy |
|
|||||
|
2023
Q3 | $356K | Buy |
|
|||||
|
2023
Q2 | $448K | Buy |
|
|||||
|
2023
Q1 | $369K | Sell |
|
|||||
|
2022
Q4 | $372K | Sell |
|
|||||
|
2022
Q3 | $668K | Buy |
|
|||||
|
2022
Q2 | $551K | Buy |
|
|||||
|
2022
Q1 | $718K | Sell |
|
|||||
|
2021
Q4 | $1.29M | Sell |
|
|||||
|
2021
Q3 | $1.48M | Buy |
|
|||||
|
2021
Q2 | $1.61M | Sell |
|
|||||
|
2021
Q1 | $844K | Sell |
|
|||||
|
2020
Q4 | $1.44M | Sell |
|
|||||
|
2020
Q3 | $540K | Buy |
|
|||||
|
2020
Q2 | $566K | Sell |
|
|||||
|
2020
Q1 | $334K | Buy |
|